We specialize in hard to find items
All Categories
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
About Syncope: Mechanisms And Management
Product Description The second edition of Syncope: Mechanisms and Management has been completely updated and revised and remains the most comprehensive textbook ever published on this common clinical entity. It provides up-to-date coverage of virtually every known cause of syncope, integrating knowledge of pathophysiology with practical guidelines for diagnosis and management. Incorporating clinical, investigative and experimental work conducted by leading authorities from all over the world, this book will serve as a practical resource for practicing cardiologists, electrophysiologists, neurologists, internists, pediatricians, and family physicians, as well as residents and fellows in these disciplines. Review 'The editors succeed in providing a comprehensive and up-to-date description of the broad scope of syncope, which makes this book a principal text in the field of syncope. The book is very well written and is an excellent addition to the library of any physician who seeks information on the causes, evaluation, and management of syncope.' Hamid Afshar (MD, Ochsner Clinic Foundation), Doodys Book Description The authors plan to include important recent information concerning syncope.There are new data from the ISSUE TrialThere are data from multicenter trials using device therapy in syncope patients showing improved survivalThere have been updates in the ACC/AHA guidelines for device implantation for syncope patientsThere are new European Society of Cardiology Guidelines regarding syncopeThere is new information regarding and new treatments for postural orthostatic tachycardia syndrome and chronic fatigue syndromeThe mechanisms of neurocardiogenic syncope are better defined. The methods to assess patients are different and new therapies have emergedThere is more general information concerning the epidemiology of syncope, its association with sudden death, and its relationship to cardiac disease.There is new and important information concerning carotid sinus hypersensitivity which will be written by one of the renowned experts in the field from the United Kingdom, Rose Kenny.There is an updated chapter on syncope in the child and adolescent.There will be updated and revised information regarding neurological issues related to syncope written by Dr. Philip Low.There will be new information regarding implantable loop recorders. Randomized clinical trials show benefit and may emphasize the earlier use of such devices in syncope patients.There is important new information concerning legal aspects of syncope and there are changes in some state laws.Dr. Mark Estes, and expert on syncope in the athlete, will write a chapter on that topic. This area may attract sports-minded physicians. This is an area in which there has been substantial advancements in knowledge.The chapters on electrophysiology testing and ventricular arrhythmias will be combined and updated.There is no competition to this book that has developed over the years. This book will continue to dominate the market regarding syncope, and those who purchased the first edition (more than 3,000) will likely want to buy the second edition with the substantial additions, improvements, edits, and changes from the first edition. From the Inside Flap Syncope: Mechanisms and Management is the principle text and sole source devoted to pathophysiological, clinical diagnostic and therapeutic information in this field. The second edition has been completely updated and remains the most comprehensive and useable reference ever published on this common clinical entity. It is a ‘must-have’ purchase providing up-to-date coverage of virtually every known cause of syncope, integrating knowledge of pathophysiology with practical guidelines for diagnosis and management. This book includes new chapters and new data from the ISSUE trial, as well as results of the multi-center trials using device therapy in patients with syncope and organic heart disease. It also contains
